Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0292879 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Julanee Leenanitikul und 12 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Computational Biology Program, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chulalongkorn University, Faculty of Medicine, Chulalongkorn University.
Abstract (Originalsprache)
Next generation sequencing of circulating tumor DNA (ctDNA) has been used as a noninvasive alternative for cancer diagnosis and characterization of tumor mutational landscape. However, low ctDNA fraction and other factors can limit the ability of ctDNA analysis to capture tumor-specific and actionable variants. In this study, whole-exome sequencings (WES) were performed on paired ctDNA and tumor biopsy in 15 cancer patients to assess the extent of concordance between mutational profiles derived from the two source materials. We found that up to 16.4% ctDNA fraction can still be insufficient for detecting tumor-specific variants and that good concordance with tumor biopsy is consistently achieved at higher ctDNA fractions. Most importantly, ctDNA analysis can consistently capture tumor heterogeneity and detect key cancer-related genes even in a patient with both primary and metastatic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics and Computational Biology Program, Chulalongkorn University, Bangkok, Thailand.
- Research Unit of Systems Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- The Queen Sirikit Center for Breast Cancer, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
- Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Medical Genetics Center, Bangkok, Thailand.
- Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Julanee Leenanitikul, Trairak Pisitkun, Sira Sriswasdi, Piriya Wongkongkathep
Förderung
- Chulalongkorn University
- Faculty of Medicine, Chulalongkorn University
Zitieren
APA
Leenanitikul, J., Chanchaem, P., Mankhong, S., Denariyakoon, S., Fongchaiya, V., Arayataweegool, A., Angspatt, P., Wongchanapai, P., Prapanpoj, V., Chatamra, K., Pisitkun, T., Sriswasdi, S., & Wongkongkathep, P. (2023). Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue. PLOS ONE. https://doi.org/10.1371/journal.pone.0292879
Vancouver
Leenanitikul J, Chanchaem P, Mankhong S, Denariyakoon S, Fongchaiya V, Arayataweegool A, et al. Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue. PLOS ONE. 2023. doi:10.1371/journal.pone.0292879
BibTeX
@article{Leenanitikul2023,
author = {Leenanitikul, Julanee and Chanchaem, Prangwalai and Mankhong, Suwanan and Denariyakoon, Sikrit and Fongchaiya, Valla and Arayataweegool, Areeya and Angspatt, Pattama and Wongchanapai, Ploytuangporn and Prapanpoj, Verayuth and Chatamra, Kris and Pisitkun, Trairak and Sriswasdi, Sira and Wongkongkathep, Piriya},
title = {Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0292879}
}
EUVIMED